Eptifibatide
COA 1 Inquiries
141732-76-5
Industrial Grade
99%
shenzhen
Customizable
5MG 10MG 20MG 30MG 60MG---1G 100G 1KG
Yes
2026-08-14
Tirzepatide,Retatrutide,Semaglutide,Cagrilintide
-
Product Details
-
Seller Information
-
Inquiry History
-
DescriptionCertificatesBasic Info
-
Product Name:
Exenatide Acetate
CAS No.:141732-76-5
Molecular Formula:C186H284N50O62S
InChIKeys:YEAXWAGAAYUUBX-JVTOQCAZSA-N
Molecular Weight:4244.60796
Exact Mass:4244.05000
Categories:
Characteristics-
PSA:
1812.35000
XLogP3:-2.07850
Research-
Class:
GLP-1 receptor agonist (exendin-based, 39-amino-acid peptide)
Status:FDA-approved (Byetta 2005, Bydureon 2012)
Mechanism:A synthetic 39-amino-acid peptide (exendin-4) that acts as a GLP-1 receptor agonist. It is not a GLP-1 analog but shares 53% sequence homology with human GLP-1. Exenatide enhances glucose-dependent insulin secretion, suppresses glucagon, slows gastric emptying, and reduces food intake. Bydureon is the extended-release formulation.
EC50 (GLP1R Ic50):3.22 nM
Source:Exendin-4 binding data: Eng J, et al. J Biol Chem. 1992;267(11):7402-7405. DrugBank: DB01276.DOI
Clinical Development:FDA:Byetta, Bydureon BCise (approved 2005-04-28)
References-
ChEMBL:
CHEMBL486
DrugBank:KEGG DRUG:PubChem:Literature:Disclaimer:Exenatide is FDA-approved as a prescription medicine (Byetta, Bydureon) for type 2 diabetes. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Tirzepatide,Retatrutide,Semaglutide,Cagrilintide
-
Location:
No.2888 Sichuan Qingbaijiang Avenue
-
Average lead Time:
7 days
-
Year of Establishment:
2025
Company Certificates-
contact
-
contract
-
-
Inquiry History1 Inquiries
Country Product Purchase Quantity Date Posted
Germany
Exenatide Acetate peptide
1000 MG May 4, 2025 Post an enquiry for this product
More from this Seller
-
-
-
Lixisenatide
Industrial Grade / 99%
$10-13/G FOB
-
-
-
-
SLU-PP-322 99% High peptide content white powder GLP/GLP-1 5mg 10mg 30mg customization
Industrial Grade / 99%
-
-
-
-
Palmitoyl Tripeptide-1
Industrial Grade / 99%
$10-13/G FOB
-
-
-
-
Degarelix
Industrial Grade / 99%
-
-
-
-
CBZ-Gly-Pro-pNA
Industrial Grade / 99%
$10-13/G FOB
-
-
-
-
5-Amino-1MQ 99% High peptide content white powder GLP/GLP-1 5mg 10mg 30mg customization
Industrial Grade / 99%
-
